Given the synthetic lethality between MK2 and p53 deletion in non-small-cell lung cancer models [6,7], we queried whether the lack of response of p53R273H glioblastoma cells is due to the different histological cancer type (lung vs. brain) or different p53 status (mutation vs. deletion). This evidence concerns the gene MAPKAPK2 and cancer.